WallStreetZenWallStreetZen

NYSEMKT: NHWK
Nighthawk Biosciences Inc Stock

Open Broker Account
$1.00-0.03 (-2.91%)
Updated Dec 9, 2022
NHWK Price
$1.00
Fair Value Price
N/A
Market Cap
$25.66M
52 Week Low
$0.99
52 Week High
$4.24
P/E
-0.56x
P/B
0.3x
P/S
6.41x
PEG
N/A
Dividend Yield
N/A
Revenue
$6.92M
Earnings
-$44.85M
Gross Margin
8%
Operating Margin
-653.65%
Profit Margin
-648.4%
Debt to Equity
0.44
Operating Cash Flow
-$9M
Beta
0.73
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NHWK Overview

Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company is headquartered in Durham, North Carolina and currently employs 30 full-time employees. The firm is an immuno-oncology company, which focuses on T cell-stimulating platform technologies, such as Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT). Using its ImPACT platform technology, the Company has developed HS-410 (vesigenurtacel-L) as a product candidate to treat non-muscle invasive bladder cancer (NMIBC), and HS-110 (viagenpumatucel-L), which is intended for use in combination with an anti-PD-1 checkpoint inhibitor, as a potential treatment for patients with non-small cell lung cancer (NSCLC). Using its ComPACT platform technology, it has developed HS-120 as a potential treatment for NSCLC. The company is conducting a Phase II trial of HS-410 in patients with NMIBC, and a Phase Ib trial of HS-110, in combination with nivolumab (Opdivo) to treat patients with NSCLC.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NHWK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NHWK is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NHWK is good value based on its book value relative to its share price (0.3x), compared to the US Biotechnology industry average (4.91x)
P/B vs Industry Valuation
NHWK is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NHWK due diligence checks available for Premium users.

Be the first to know about important NHWK news, forecast changes, insider trades & much more!

NHWK News

Valuation

NHWK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.56x
Industry
13.17x
Market
21.21x

NHWK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.3x
Industry
4.91x
NHWK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NHWK's financial health

Profit margin

Revenue
$6.0M
Net Income
-$13.0M
Profit Margin
-215.3%
NHWK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NHWK's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$120.2M
Liabilities
$37.0M
Debt to equity
0.44
NHWK's short-term assets ($66.47M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NHWK's short-term assets ($66.47M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NHWK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NHWK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$3.6M
Investing
-$148.4k
Financing
-$34.5k
NHWK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NHWK vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
NHWK$25.66M-2.44%-0.56x0.30x
ZIVO$26.00M-1.43%-2.65x17.06x
MRKR$25.08M+5.63%-0.70x1.11x
ANGN$25.05M+0.24%-1.66x0.50x
ACHV$25.05M+0.78%-0.66x24.00x

Nighthawk Biosciences Stock FAQ

What is Nighthawk Biosciences's quote symbol?

NYSEMKT: NHWK) Nighthawk Biosciences trades on the NYSEMKT under the ticker symbol NHWK. Nighthawk Biosciences stock quotes can also be displayed as NYSEMKT: NHWK.

If you're new to stock investing, here's how to buy Nighthawk Biosciences stock.

What is the 52 week high and low for Nighthawk Biosciences (NYSEMKT: NHWK)?

(NYSEMKT: NHWK) Nighthawk Biosciences's 52-week high was $4.24, and its 52-week low was $0.99. It is currently -76.39% from its 52-week high and 1.01% from its 52-week low.

How much is Nighthawk Biosciences stock worth today?

(NYSEMKT: NHWK) Nighthawk Biosciences currently has 25,661,488 outstanding shares. With Nighthawk Biosciences stock trading at $1.00 per share, the total value of Nighthawk Biosciences stock (market capitalization) is $25.66M.

Nighthawk Biosciences stock was originally listed at a price of $669.90 in Jul 24, 2013. If you had invested in Nighthawk Biosciences stock at $669.90, your return over the last 9 years would have been -99.85%, for an annualized return of -51.47% (not including any dividends or dividend reinvestments).

How much is Nighthawk Biosciences's stock price per share?

(NYSEMKT: NHWK) Nighthawk Biosciences stock price per share is $1.00 today (as of Dec 9, 2022).

What is Nighthawk Biosciences's Market Cap?

(NYSEMKT: NHWK) Nighthawk Biosciences's market cap is $25.66M, as of Dec 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nighthawk Biosciences's market cap is calculated by multiplying NHWK's current stock price of $1.00 by NHWK's total outstanding shares of 25,661,488.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.